Search research articles
Contact Us
Filters
Showing results (41-50 of 52) with videos related to
Page
of 6
Sort By:
Trials
|
November 21, 2014
CASPER plus (CollAborative care in Screen-Positive EldeRs with major depressive disorder): study protocol for a randomised controlled trial
Karen Overend, Helen Lewis, Della Bailey, et al.
Pilot and Feasibility Studies
|
June 5, 2019
Community Pharmacies Mood Intervention Study (CHEMIST): feasibility and external pilot randomised controlled trial protocol
Elizabeth Littlewood, Shehzad Ali, Jay Badenhorst, et al.
Pilot and Feasibility Studies
|
February 4, 2022
The feasibility and acceptability of a brief psychological intervention for adults with long-term health conditions and subthreshold depression delivered via community pharmacies: a mixed methods evaluation-the Community Pharmacies Mood Intervention Study (CHEMIST)
Carolyn A Chew-Graham, Charlotte E W Kitchen, Samantha Gascoyne, et al.
Journal of Affective Disorders
|
December 8, 2024
A randomised controlled feasibility trial of Behavioural activation as a treatment for people with diabetes and depression: (DiaDeM feasibility trial)
Naveed Ahmed, Gerardo A Zavala, Faraz Siddiqui, et al.
Health Technology Assessment (Winchester, England)
|
September 1, 2017
Cost and Outcome of BehaviouRal Activation (COBRA): a randomised controlled trial of behavioural activation versus cognitive-behavioural therapy for depression
David A Richards, Shelley Rhodes, David Ekers, et al.
Plos Medicine
|
October 12, 2021
Behavioural activation to prevent depression and loneliness among socially isolated older people with long-term conditions: The BASIL COVID-19 pilot randomised controlled trial
Simon Gilbody, Elizabeth Littlewood, Dean McMillan, et al.
Plos One
|
March 24, 2022
Behavioural Activation for Social IsoLation (BASIL+) trial (Behavioural activation to mitigate depression and loneliness among older people with long-term conditions): Protocol for a fully-powered pragmatic randomised controlled trial
Lauren Burke, Elizabeth Littlewood, Samantha Gascoyne, et al.
The Lancet. Healthy Longevity
|
February 4, 2024
Behavioural activation to mitigate the psychological impacts of COVID-19 restrictions on older people in England and Wales (BASIL+): a pragmatic randomised controlled trial
Simon Gilbody, Elizabeth Littlewood, Dean McMillan, et al.
Evidence-Based Mental Health
|
October 12, 2022
Can we mitigate the psychological impacts of social isolation using behavioural activation? Long-term results of the UK BASIL urgent public health COVID-19 pilot randomised controlled trial and living systematic review
Elizabeth Littlewood, Dean McMillan, Carolyn Chew Graham, et al.
JAMA
|
February 28, 2017
Effect of Collaborative Care vs Usual Care on Depressive Symptoms in Older Adults With Subthreshold Depression: The CASPER Randomized Clinical Trial
Simon Gilbody, Helen Lewis, Joy Adamson, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 52) with videos related to
Sort By:
Page
of 6
Trials
|
November 21, 2014
CASPER plus (CollAborative care in Screen-Positive EldeRs with major depressive disorder): study protocol for a randomised controlled trial
Karen Overend, Helen Lewis, Della Bailey, et al.
Pilot and Feasibility Studies
|
June 5, 2019
Community Pharmacies Mood Intervention Study (CHEMIST): feasibility and external pilot randomised controlled trial protocol
Elizabeth Littlewood, Shehzad Ali, Jay Badenhorst, et al.
Pilot and Feasibility Studies
|
February 4, 2022
The feasibility and acceptability of a brief psychological intervention for adults with long-term health conditions and subthreshold depression delivered via community pharmacies: a mixed methods evaluation-the Community Pharmacies Mood Intervention Study (CHEMIST)
Carolyn A Chew-Graham, Charlotte E W Kitchen, Samantha Gascoyne, et al.
Journal of Affective Disorders
|
December 8, 2024
A randomised controlled feasibility trial of Behavioural activation as a treatment for people with diabetes and depression: (DiaDeM feasibility trial)
Naveed Ahmed, Gerardo A Zavala, Faraz Siddiqui, et al.
Health Technology Assessment (Winchester, England)
|
September 1, 2017
Cost and Outcome of BehaviouRal Activation (COBRA): a randomised controlled trial of behavioural activation versus cognitive-behavioural therapy for depression
David A Richards, Shelley Rhodes, David Ekers, et al.
Plos Medicine
|
October 12, 2021
Behavioural activation to prevent depression and loneliness among socially isolated older people with long-term conditions: The BASIL COVID-19 pilot randomised controlled trial
Simon Gilbody, Elizabeth Littlewood, Dean McMillan, et al.
Plos One
|
March 24, 2022
Behavioural Activation for Social IsoLation (BASIL+) trial (Behavioural activation to mitigate depression and loneliness among older people with long-term conditions): Protocol for a fully-powered pragmatic randomised controlled trial
Lauren Burke, Elizabeth Littlewood, Samantha Gascoyne, et al.
The Lancet. Healthy Longevity
|
February 4, 2024
Behavioural activation to mitigate the psychological impacts of COVID-19 restrictions on older people in England and Wales (BASIL+): a pragmatic randomised controlled trial
Simon Gilbody, Elizabeth Littlewood, Dean McMillan, et al.
Evidence-Based Mental Health
|
October 12, 2022
Can we mitigate the psychological impacts of social isolation using behavioural activation? Long-term results of the UK BASIL urgent public health COVID-19 pilot randomised controlled trial and living systematic review
Elizabeth Littlewood, Dean McMillan, Carolyn Chew Graham, et al.
JAMA
|
February 28, 2017
Effect of Collaborative Care vs Usual Care on Depressive Symptoms in Older Adults With Subthreshold Depression: The CASPER Randomized Clinical Trial
Simon Gilbody, Helen Lewis, Joy Adamson, et al.
Page
of 6